Related Experiment Videos
[Facioscapulohumeral muscular dystrophy (FSHD)]
1Department of Neuromuscular Research, National Institute of Neuroscience, NCNP.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|January 22, 1998
Summary
Facioscapulohumeral muscular dystrophy (FSHD) is a common inherited muscle disorder. Most FSHD cases (FSHD1A) involve a specific DNA deletion on chromosome 4, but rare forms (FSHD1B) show genetic heterogeneity.
Area of Science:
- Genetics
- Molecular Biology
- Neurology
Context:
- Facioscapulohumeral muscular dystrophy (FSHD) is a significant inherited neuromuscular disorder.
- It follows an autosomal dominant inheritance pattern.
- FSHD presents diagnostic challenges due to genetic heterogeneity.
Purpose:
- To review the genetic basis of FSHD, focusing on molecular diagnostics.
- To highlight the association of 4q35 DNA deletions with FSHD1A.
- To acknowledge the existence of 4q35-unlinked FSHD (FSHD1B).
Summary:
- The majority of FSHD cases (FSHD1A) are linked to a deletion of tandemly repeated units in the 4q35 region, detectable by the p13E-11 probe.
- Molecular diagnosis has improved (>95% accuracy) by distinguishing 4q35 and 10q26 EcoRI fragments.
- Rare FSHD cases (FSHD1B) are not linked to 4q35, indicating genetic heterogeneity.
Impact:
- Improved molecular diagnostic accuracy for FSHD.
- Underscores the need for further research into the unidentified gene responsible for FSHD1A.
- Highlights the importance of understanding genetic heterogeneity in FSHD for future therapeutic strategies.